Pegvisomant home care programme leading to rapid IGF1 control likely improves quality of life [PDF]
Els Rutten +4 more
openalex +1 more source
The Impact of Pegvisomant Treatment on Substrate Metabolism and Insulin Sensitivity in Patients with Acromegaly [PDF]
Rune Lindberg-Larsen +6 more
openalex +1 more source
Effects of treatment for acromegaly on bone mineral density: is pegvisomant protective on lumbar BMD? [PDF]
Giulia Brigante +8 more
openalex +1 more source
Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
Ji-wen Wang,1,2 Ying Li,3 Zhi-gang Mao,1,2 Bin Hu,1,2 Xiao-bing Jiang,1,2 Bing-bing Song,4 Xin Wang,4 Yong-hong Zhu,4 Hai-jun Wang1,21Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital, Sun Yat-sen University, 2Key ...
Wang JW +8 more
doaj
Pegvisomant as add-on to somatostatin analogue therapy [PDF]
Linda Koch
openalex +1 more source
Evolución de pacientes operados de tumor de hipofisis en el servicio de neurocirugía del Hospital escuela Antonio Lenin Fonseca [PDF]
Se realizó este estudio de Cohortes prospectivas en el servicio de Neurocirugía del Hospital Escuela Antonio Lenin Fonseca en el período comprendido del 9 de Febrero del 2015 al 12 de Enero del 2016 que trata sobre la evolución de 26 pacientes operados ...
González, Arlen, Hernández, Rolando
core
Optimal use of pegvisomant in acromegaly: are we getting there? [PDF]
Andrea Giustina
openalex +1 more source
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues [PDF]
Sanne Franck +15 more
openalex +1 more source

